| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | CA2429636A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221482A1 Novel hemopoietin receptor protein, nr12 |
| 07/10/2002 | EP1221476A2 Culture medium for CHO-cells and adapted CHO-cells |
| 07/10/2002 | EP1221045A2 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220944A1 Nuclease inhibitor cocktail |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220923A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIVES |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220914A1 Human g-protein coupled receptor |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220905A2 Composition and methods for the treatment of immune related diseases |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220864A1 Transgenically produced fusion proteins |
| 07/10/2002 | EP1220687A1 Administration of gamma globulins to treat lymphoma |
| 07/10/2002 | EP1220686A2 Vaccine against neisseria infection |
| 07/10/2002 | EP0934427A4 Rh blood group antigen compositions and methods of use |
| 07/10/2002 | EP0931162A4 Production of a multimeric protein by cell fusion method |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | EP0517805B1 Identification and expression of insect steroid receptor dna sequences |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358100A Manufacturing method for intravenous immune globulin and resul tant product |
| 07/10/2002 | CN1357552A New polypeptide laminin B211.22 and polynucleotides encoding this polypeptide |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6418338 Method for detecting and surgically removing lymphoid tissue involved in tumor progression |
| 07/09/2002 | US6417429 Genetic engineering |
| 07/09/2002 | US6417337 Derived from a murine antibody that binds carcinoembryonic antigen (cea); anticarcinogenic -tumor agents; diagnosis; nucleic acid sequence and vectors thereof |
| 07/09/2002 | US6417336 Antibody against cleavage product or vimentin |
| 07/09/2002 | US6417335 Protein purification |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417328 Isolated genes encoding tumor necrosis factor-related apotosis-inducing ligand (trail) receptor splice variant cdna sequences, or active fragment; immunogens, modulation therapeutic autoimmune diseases, aids |
| 07/09/2002 | US6417324 Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417165 NY-ESO-1-peptide derivatives, and uses thereof |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416974 Tango 71 nucleic acids |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416968 Methods of inhibiting Helicobacter pylori |
| 07/09/2002 | US6416963 Cleaved fragments of fibrinogen |
| 07/09/2002 | US6416958 Antibody binds an epitope on the hla-dr polypeptide and induces apoptosis in cells expressing hla-dr, without concomitant suppression of hla-dr dependent immune responses. |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416760 Therapeutic/cosmetic formulation for therapeutical treatment or care of sensitive human skin, hair, mucous membrane, nails and/or the scalp comprises a calcitonin gene related peptide (cgrp) antagonist and a carrier, diluent or vehicle |
| 07/09/2002 | US6416759 Antiproliferative Sgk reagents and methods |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | US6416757 Tumor necrosis factor antibodies |
| 07/09/2002 | US6416753 Method for modulating apoptosis |
| 07/09/2002 | CA2222275C Fluorinated xanthene derivatives |
| 07/09/2002 | CA2096495C Dual analyte immunoassay |
| 07/09/2002 | CA2077434C Antigenic proteins of borrelia burgdorferi |
| 07/09/2002 | CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 |
| 07/09/2002 | CA1341375C Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 07/05/2002 | CA2367001A1 The method for production of egg containing anti-e.coli igy and anti-helicobacter pylori igy and anti-salmonella enteritidis igy and anti-salmonella typhimurium igy simultaneously, and egg, yolk, yogurt and ice cream containing specific igy for anti-e.coli, anti-helicobacter pylori, anti-salmonella enteritidis and anti-salmonella typhimurium |
| 07/04/2002 | WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2002052012A2 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | WO2002052011A2 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052000A1 Novel potassium channel |
| 07/04/2002 | WO2002051998A1 Novel protease |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051870A2 Phage display libraries of human vh fragments |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051863A2 Polypeptides having a triggering nk activity and biological applications |
| 07/04/2002 | WO2002051448A1 Anti-tenascin monoclonal antibody therapy for lymphoma |
| 07/04/2002 | WO2002051439A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051351A2 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 07/04/2002 | WO2002051254A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002033042A3 Recombinant antibody fragments as autoantibody antagonists |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002023202A8 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |